News
Former Horizon CFO joins Galapagos with deep expertise in international corporate finance, M&A, business development and strategic leadership Mechelen, Belgium; June 23, 2025, 07:30 CET; regulated ...
Former Horizon CFO joins Galapagos with deep expertise in international corporate finance, M&A, business development and strategic leadership Mechelen, Belgium; June 23, 2025, 07:30 CET; regulated ...
MariTide, the First Monthly or Less Frequently Dosed Obesity Treatment, Demonstrated Up to ~20% Average Weight Loss Without a Weight Loss Plateau, and Delivered Significant ...
1d
Medpage Today on MSNIBD Biomarkers: Established Tests Are Helpful but Clinicians Want MoreTwo biomarker tests -- one for blood and the other for stool -- are mainstays in the treatment of inflammatory bowel disease ...
Structured, long-term, co-located and co-funded partnerships between industry and academia are the way forward ...
4d
Barchart on MSNAre These 2 'Strong Buy' Rated Growth Stocks Buys Right Now?Investing in biotech penny stocks is fraught with volatility, regulatory hurdles, and uncertain clinical results. Penny ...
Pfizer's stock, after facing post-pandemic market blues, is showing glimmers of a comeback. The stock recently logged a 4.10% ...
Novartis AG offers growth potential with a balanced drug portfolio, manageable debt, and shares priced below fair value. Click for my updated look at NVS stock.
Ratio Therapeutics and Ionetix have inked separate deals to boost production of the much-needed radioisotope actinium-225, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results